HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 16-NOV-15 5ESG TITLE SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E TITLE 2 MUTANT COMPLEXED WITH ITRACONAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LANOSTEROL 14-ALPHA DEMETHYLASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.14.13.70; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE (STRAIN YJM789); SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 307796; SOURCE 5 STRAIN: YJM789; SOURCE 6 GENE: ERG11, SCY_2394; SOURCE 7 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: AD2DELTA KEYWDS CYP51, OXIDOREDUCTASE-OXIDOREDUCATSE INHIBITOR COMPLEX, MUTATION, KEYWDS 2 OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.SAGATOVA,M.V.KENIYA,R.K.WILSON,M.SABHERWAL,J.D.A.TYNDALL,B.C.MONK REVDAT 5 27-SEP-23 5ESG 1 REMARK REVDAT 4 01-SEP-21 5ESG 1 JRNL REVDAT 3 01-JAN-20 5ESG 1 REMARK REVDAT 2 20-SEP-17 5ESG 1 REMARK REVDAT 1 23-NOV-16 5ESG 0 JRNL AUTH A.A.SAGATOVA,M.V.KENIYA,J.D.A.TYNDALL,B.C.MONK JRNL TITL IMPACT OF HOMOLOGOUS RESISTANCE MUTATIONS FROM PATHOGENIC JRNL TITL 2 YEAST ON SACCHAROMYCES CEREVISIAE LANOSTEROL 14 JRNL TITL 3 ALPHA-DEMETHYLASE. JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 62 2018 JRNL REFN ESSN 1098-6596 JRNL PMID 29263059 JRNL DOI 10.1128/AAC.02242-17 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.C.MONK,T.M.TOMASIAK,M.V.KENIYA,F.U.HUSCHMANN,J.D.TYNDALL, REMARK 1 AUTH 2 J.D.O'CONNELL,R.D.CANNON,J.G.MCDONALD,A.RODRIGUEZ, REMARK 1 AUTH 3 J.S.FINER-MOORE,R.M.STROUD REMARK 1 TITL ARCHITECTURE OF A SINGLE MEMBRANE SPANNING CYTOCHROME P450 REMARK 1 TITL 2 SUGGESTS CONSTRAINTS THAT ORIENT THE CATALYTIC DOMAIN REMARK 1 TITL 3 RELATIVE TO A BILAYER. REMARK 1 REF PROC. NATL. ACAD. SCI. V. 111 3865 2014 REMARK 1 REF 2 U.S.A. REMARK 1 REFN ESSN 1091-6490 REMARK 1 PMID 24613931 REMARK 1 DOI 10.1073/PNAS.1324245111 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.A.SAGATOVA,M.V.KENIYA,R.K.WILSON,B.C.MONK,J.D.TYNDALL REMARK 1 TITL STRUCTURAL INSIGHTS INTO BINDING OF THE ANTIFUNGAL DRUG REMARK 1 TITL 2 FLUCONAZOLE TO SACCHAROMYCES CEREVISIAE LANOSTEROL REMARK 1 TITL 3 14ALPHA-DEMETHYLASE. REMARK 1 REF ANTIMICROB. AGENTS V. 59 4982 2015 REMARK 1 REF 2 CHEMOTHER. REMARK 1 REFN ESSN 1098-6596 REMARK 1 PMID 26055382 REMARK 1 DOI 10.1128/AAC.00925-15 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.4_1496 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.66 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 57667 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 2899 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.6598 - 5.4581 0.99 2695 141 0.1894 0.2268 REMARK 3 2 5.4581 - 4.3352 1.00 2654 140 0.1636 0.1796 REMARK 3 3 4.3352 - 3.7880 1.00 2620 154 0.1719 0.2347 REMARK 3 4 3.7880 - 3.4421 1.00 2625 143 0.1766 0.2086 REMARK 3 5 3.4421 - 3.1956 1.00 2618 136 0.2055 0.2494 REMARK 3 6 3.1956 - 3.0073 1.00 2603 136 0.2000 0.2107 REMARK 3 7 3.0073 - 2.8567 1.00 2630 155 0.1943 0.1995 REMARK 3 8 2.8567 - 2.7324 1.00 2617 129 0.1971 0.2470 REMARK 3 9 2.7324 - 2.6273 1.00 2596 143 0.1964 0.2374 REMARK 3 10 2.6273 - 2.5367 1.00 2633 122 0.1891 0.2099 REMARK 3 11 2.5367 - 2.4574 1.00 2594 133 0.1943 0.2248 REMARK 3 12 2.4574 - 2.3872 1.00 2602 138 0.1990 0.2539 REMARK 3 13 2.3872 - 2.3243 1.00 2636 116 0.2022 0.2923 REMARK 3 14 2.3243 - 2.2676 1.00 2620 150 0.2162 0.2561 REMARK 3 15 2.2676 - 2.2161 1.00 2578 141 0.2339 0.2462 REMARK 3 16 2.2161 - 2.1689 1.00 2584 149 0.2427 0.2786 REMARK 3 17 2.1689 - 2.1256 1.00 2587 143 0.2662 0.2821 REMARK 3 18 2.1256 - 2.0855 1.00 2622 141 0.2728 0.3046 REMARK 3 19 2.0855 - 2.0482 1.00 2586 128 0.3104 0.3958 REMARK 3 20 2.0482 - 2.0135 1.00 2618 132 0.3165 0.3625 REMARK 3 21 2.0135 - 1.9810 0.95 2450 129 0.3340 0.3727 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4482 REMARK 3 ANGLE : 1.065 6088 REMARK 3 CHIRALITY : 0.042 642 REMARK 3 PLANARITY : 0.005 802 REMARK 3 DIHEDRAL : 13.953 1684 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ESG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1000214200. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-13 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 9.3-9.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57704 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 37.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.97500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4LXJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG-400 45%, 0.1 M GLYCINE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.65500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 LYS A 5 REMARK 465 SER A 6 REMARK 465 ILE A 7 REMARK 465 HIS A 534 REMARK 465 HIS A 535 REMARK 465 HIS A 536 REMARK 465 HIS A 537 REMARK 465 HIS A 538 REMARK 465 HIS A 539 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 65 -57.19 66.53 REMARK 500 THR A 130 -41.24 -135.00 REMARK 500 ILE A 139 -96.85 61.82 REMARK 500 ASP A 141 51.37 -108.29 REMARK 500 LEU A 158 54.28 -110.34 REMARK 500 PHE A 184 -78.73 -120.71 REMARK 500 PRO A 247 61.50 -66.63 REMARK 500 ASP A 277 55.48 -90.80 REMARK 500 GLN A 279 -140.55 -120.57 REMARK 500 ASN A 290 78.80 -154.49 REMARK 500 SER A 291 37.05 -153.67 REMARK 500 MET A 363 73.19 -116.06 REMARK 500 ASP A 434 58.08 -160.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 702 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 470 SG REMARK 620 2 HEM A 702 NA 95.7 REMARK 620 3 HEM A 702 NB 89.3 88.5 REMARK 620 4 HEM A 702 NC 86.3 178.0 91.2 REMARK 620 5 HEM A 702 ND 93.4 91.0 177.3 89.3 REMARK 620 6 1YN A 701 N39 177.0 87.3 90.3 90.7 87.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1YN A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 702 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5ESE RELATED DB: PDB REMARK 900 RELATED ID: 5ESF RELATED DB: PDB REMARK 900 RELATED ID: 5ESH RELATED DB: PDB REMARK 900 RELATED ID: 5ESM RELATED DB: PDB REMARK 900 RELATED ID: 5ESN RELATED DB: PDB REMARK 900 RELATED ID: 5ESI RELATED DB: PDB REMARK 900 RELATED ID: 5ESK RELATED DB: PDB REMARK 900 RELATED ID: 5ESL RELATED DB: PDB REMARK 900 RELATED ID: 5ESJ RELATED DB: PDB DBREF 5ESG A 1 530 UNP A6ZSR0 A6ZSR0_YEAS7 1 530 SEQADV 5ESG GLU A 73 UNP A6ZSR0 GLY 73 ENGINEERED MUTATION SEQADV 5ESG GLY A 531 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESG GLY A 532 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESG ARG A 533 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESG HIS A 534 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESG HIS A 535 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESG HIS A 536 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESG HIS A 537 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESG HIS A 538 UNP A6ZSR0 EXPRESSION TAG SEQADV 5ESG HIS A 539 UNP A6ZSR0 EXPRESSION TAG SEQRES 1 A 539 MET SER ALA THR LYS SER ILE VAL GLY GLU ALA LEU GLU SEQRES 2 A 539 TYR VAL ASN ILE GLY LEU SER HIS PHE LEU ALA LEU PRO SEQRES 3 A 539 LEU ALA GLN ARG ILE SER LEU ILE ILE ILE ILE PRO PHE SEQRES 4 A 539 ILE TYR ASN ILE VAL TRP GLN LEU LEU TYR SER LEU ARG SEQRES 5 A 539 LYS ASP ARG PRO PRO LEU VAL PHE TYR TRP ILE PRO TRP SEQRES 6 A 539 VAL GLY SER ALA VAL VAL TYR GLU MET LYS PRO TYR GLU SEQRES 7 A 539 PHE PHE GLU GLU CYS GLN LYS LYS TYR GLY ASP ILE PHE SEQRES 8 A 539 SER PHE VAL LEU LEU GLY ARG VAL MET THR VAL TYR LEU SEQRES 9 A 539 GLY PRO LYS GLY HIS GLU PHE VAL PHE ASN ALA LYS LEU SEQRES 10 A 539 ALA ASP VAL SER ALA GLU ALA ALA TYR ALA HIS LEU THR SEQRES 11 A 539 THR PRO VAL PHE GLY LYS GLY VAL ILE TYR ASP CYS PRO SEQRES 12 A 539 ASN SER ARG LEU MET GLU GLN LYS LYS PHE VAL LYS GLY SEQRES 13 A 539 ALA LEU THR LYS GLU ALA PHE LYS SER TYR VAL PRO LEU SEQRES 14 A 539 ILE ALA GLU GLU VAL TYR LYS TYR PHE ARG ASP SER LYS SEQRES 15 A 539 ASN PHE ARG LEU ASN GLU ARG THR THR GLY THR ILE ASP SEQRES 16 A 539 VAL MET VAL THR GLN PRO GLU MET THR ILE PHE THR ALA SEQRES 17 A 539 SER ARG SER LEU LEU GLY LYS GLU MET ARG ALA LYS LEU SEQRES 18 A 539 ASP THR ASP PHE ALA TYR LEU TYR SER ASP LEU ASP LYS SEQRES 19 A 539 GLY PHE THR PRO ILE ASN PHE VAL PHE PRO ASN LEU PRO SEQRES 20 A 539 LEU GLU HIS TYR ARG LYS ARG ASP HIS ALA GLN LYS ALA SEQRES 21 A 539 ILE SER GLY THR TYR MET SER LEU ILE LYS GLU ARG ARG SEQRES 22 A 539 LYS ASN ASN ASP ILE GLN ASP ARG ASP LEU ILE ASP SER SEQRES 23 A 539 LEU MET LYS ASN SER THR TYR LYS ASP GLY VAL LYS MET SEQRES 24 A 539 THR ASP GLN GLU ILE ALA ASN LEU LEU ILE GLY VAL LEU SEQRES 25 A 539 MET GLY GLY GLN HIS THR SER ALA ALA THR SER ALA TRP SEQRES 26 A 539 ILE LEU LEU HIS LEU ALA GLU ARG PRO ASP VAL GLN GLN SEQRES 27 A 539 GLU LEU TYR GLU GLU GLN MET ARG VAL LEU ASP GLY GLY SEQRES 28 A 539 LYS LYS GLU LEU THR TYR ASP LEU LEU GLN GLU MET PRO SEQRES 29 A 539 LEU LEU ASN GLN THR ILE LYS GLU THR LEU ARG MET HIS SEQRES 30 A 539 HIS PRO LEU HIS SER LEU PHE ARG LYS VAL MET LYS ASP SEQRES 31 A 539 MET HIS VAL PRO ASN THR SER TYR VAL ILE PRO ALA GLY SEQRES 32 A 539 TYR HIS VAL LEU VAL SER PRO GLY TYR THR HIS LEU ARG SEQRES 33 A 539 ASP GLU TYR PHE PRO ASN ALA HIS GLN PHE ASN ILE HIS SEQRES 34 A 539 ARG TRP ASN ASN ASP SER ALA SER SER TYR SER VAL GLY SEQRES 35 A 539 GLU GLU VAL ASP TYR GLY PHE GLY ALA ILE SER LYS GLY SEQRES 36 A 539 VAL SER SER PRO TYR LEU PRO PHE GLY GLY GLY ARG HIS SEQRES 37 A 539 ARG CYS ILE GLY GLU HIS PHE ALA TYR CYS GLN LEU GLY SEQRES 38 A 539 VAL LEU MET SER ILE PHE ILE ARG THR LEU LYS TRP HIS SEQRES 39 A 539 TYR PRO GLU GLY LYS THR VAL PRO PRO PRO ASP PHE THR SEQRES 40 A 539 SER MET VAL THR LEU PRO THR GLY PRO ALA LYS ILE ILE SEQRES 41 A 539 TRP GLU LYS ARG ASN PRO GLU GLN LYS ILE GLY GLY ARG SEQRES 42 A 539 HIS HIS HIS HIS HIS HIS HET 1YN A 701 49 HET HEM A 702 43 HETNAM 1YN 2-[(2R)-BUTAN-2-YL]-4-{4-[4-(4-{[(2R,4S)-2-(2,4- HETNAM 2 1YN DICHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3- HETNAM 3 1YN DIOXOLAN-4-YL]METHOXY}PHENYL)PIPERAZIN-1-YL]PHENYL}-2, HETNAM 4 1YN 4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN 1YN ITRACONAZOLE HETSYN HEM HEME FORMUL 2 1YN C35 H38 CL2 N8 O4 FORMUL 3 HEM C34 H32 FE N4 O4 FORMUL 4 HOH *157(H2 O) HELIX 1 AA1 VAL A 8 ALA A 24 1 17 HELIX 2 AA2 PRO A 26 SER A 50 1 25 HELIX 3 AA3 SER A 68 LYS A 75 1 8 HELIX 4 AA4 LYS A 75 GLY A 88 1 14 HELIX 5 AA5 GLY A 105 ASN A 114 1 10 HELIX 6 AA6 ALA A 122 GLY A 135 1 14 HELIX 7 AA7 PRO A 143 GLY A 156 1 14 HELIX 8 AA8 THR A 159 SER A 181 1 23 HELIX 9 AA9 VAL A 196 LEU A 213 1 18 HELIX 10 AB1 GLY A 214 LEU A 221 1 8 HELIX 11 AB2 ASP A 222 ASP A 224 5 3 HELIX 12 AB3 PHE A 225 GLY A 235 1 11 HELIX 13 AB4 PHE A 236 VAL A 242 5 7 HELIX 14 AB5 LEU A 248 LYS A 274 1 27 HELIX 15 AB6 ASP A 282 ASN A 290 1 9 HELIX 16 AB7 THR A 300 GLU A 332 1 33 HELIX 17 AB8 ARG A 333 LEU A 348 1 16 HELIX 18 AB9 THR A 356 GLN A 361 1 6 HELIX 19 AC1 MET A 363 HIS A 377 1 15 HELIX 20 AC2 SER A 409 HIS A 414 1 6 HELIX 21 AC3 ASN A 427 ASN A 432 5 6 HELIX 22 AC4 GLY A 465 ARG A 469 5 5 HELIX 23 AC5 GLY A 472 THR A 490 1 19 SHEET 1 AA1 5 ILE A 90 LEU A 95 0 SHEET 2 AA1 5 ARG A 98 TYR A 103 -1 O ARG A 98 N LEU A 95 SHEET 3 AA1 5 HIS A 405 VAL A 408 1 O HIS A 405 N THR A 101 SHEET 4 AA1 5 LEU A 383 VAL A 387 -1 N LEU A 383 O VAL A 408 SHEET 5 AA1 5 VAL A 120 SER A 121 -1 N SER A 121 O LYS A 386 SHEET 1 AA2 3 THR A 191 ASP A 195 0 SHEET 2 AA2 3 LYS A 518 LYS A 523 -1 O ILE A 519 N ILE A 194 SHEET 3 AA2 3 LEU A 491 HIS A 494 -1 N HIS A 494 O ILE A 520 SHEET 1 AA3 2 MET A 391 HIS A 392 0 SHEET 2 AA3 2 VAL A 399 ILE A 400 -1 O ILE A 400 N MET A 391 SHEET 1 AA4 2 GLU A 444 ASP A 446 0 SHEET 2 AA4 2 ALA A 451 SER A 453 -1 O ILE A 452 N VAL A 445 LINK SG CYS A 470 FE HEM A 702 1555 1555 2.31 LINK N39 1YN A 701 FE HEM A 702 1555 1555 2.12 CISPEP 1 GLY A 515 PRO A 516 0 -1.35 SITE 1 AC1 20 GLU A 73 LEU A 96 TYR A 126 PHE A 134 SITE 2 AC1 20 ILE A 139 TYR A 140 PHE A 236 PRO A 238 SITE 3 AC1 20 ILE A 239 GLY A 310 VAL A 311 GLY A 314 SITE 4 AC1 20 THR A 318 HIS A 381 SER A 382 PHE A 384 SITE 5 AC1 20 SER A 508 MET A 509 HEM A 702 HOH A 873 SITE 1 AC2 20 PHE A 113 TYR A 126 TYR A 140 LEU A 147 SITE 2 AC2 20 LYS A 151 GLY A 315 THR A 318 LEU A 374 SITE 3 AC2 20 PRO A 379 LEU A 383 ARG A 385 PRO A 462 SITE 4 AC2 20 PHE A 463 GLY A 464 HIS A 468 CYS A 470 SITE 5 AC2 20 ILE A 471 GLY A 472 1YN A 701 HOH A 861 CRYST1 78.240 67.310 80.830 90.00 98.65 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012781 0.000000 0.001944 0.00000 SCALE2 0.000000 0.014857 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012514 0.00000